Anthropometric variables as cardiovascular risk predictors in a cohort of adult subjects with Turner syndrome.
Turner syndrome
anthropometric indexes
body composition
cardiometabolic risk
metabolic syndrome
obesity
overweight
Journal
Diabetes, metabolic syndrome and obesity : targets and therapy
ISSN: 1178-7007
Titre abrégé: Diabetes Metab Syndr Obes
Pays: New Zealand
ID NLM: 101515585
Informations de publication
Date de publication:
2019
2019
Historique:
received:
07
05
2019
accepted:
23
07
2019
entrez:
2
10
2019
pubmed:
2
10
2019
medline:
2
10
2019
Statut:
epublish
Résumé
Excessive adiposity is associated with cardiometabolic complications in Turner syndrome (TS) subjects. Reference data for predictive anthropometric indices of overweight/obesity and metabolic syndrome (MetS) are lacking for subjects with TS. The purpose of this study was to identify the best anthropometric predictor of cardiometabolic risk in a Latin-American cohort of TS subjects. This was a cross-sectional correlational study conducted in adult TS subjects (n=88) over the past seven years. Anthropometric parameters, body composition and biochemical variables were evaluated in a study and in a reference (n=57) group. Overweight/obesity and MetS were diagnosed using international consensus. The area under the ROC curve (AUC-ROC) was then used to determine the value of each anthropometric variable in predicting MetS or overweight/obesity. The prevalence of MetS and overweight/obesity in TS subjects was 40% and 48%, respectively. All anthropometric and cardiometabolic variables were significantly increased in TS subjects when compared to the reference group, except for body mass index (BMI) and HDL-c. To detect MetS and overweight/obesity, waist to height ratio (WHtR) was found to have a higher correlation with cardiometabolic variables (TC, LDL-c, HDL-c levels and the LDL-c/HDL-c ratio), and to have a higher AUC-ROC and odds ratio than BMI, waist circumference (WC) and the waist to hip ratio (WHR). The prevalence of MetS and overweight/obesity is elevated in TS subjects. WHtR was the most useful variable in predicting the presence of MetS and overweight and obesity in this TS cohort. A combination of WHtR with BMI or with WC could have the best clinical utility in identifying adult TS subjects with overweight/obesity and MetS, respectively.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Excessive adiposity is associated with cardiometabolic complications in Turner syndrome (TS) subjects. Reference data for predictive anthropometric indices of overweight/obesity and metabolic syndrome (MetS) are lacking for subjects with TS. The purpose of this study was to identify the best anthropometric predictor of cardiometabolic risk in a Latin-American cohort of TS subjects.
PATIENTS AND METHODS
METHODS
This was a cross-sectional correlational study conducted in adult TS subjects (n=88) over the past seven years. Anthropometric parameters, body composition and biochemical variables were evaluated in a study and in a reference (n=57) group. Overweight/obesity and MetS were diagnosed using international consensus. The area under the ROC curve (AUC-ROC) was then used to determine the value of each anthropometric variable in predicting MetS or overweight/obesity.
RESULTS
RESULTS
The prevalence of MetS and overweight/obesity in TS subjects was 40% and 48%, respectively. All anthropometric and cardiometabolic variables were significantly increased in TS subjects when compared to the reference group, except for body mass index (BMI) and HDL-c. To detect MetS and overweight/obesity, waist to height ratio (WHtR) was found to have a higher correlation with cardiometabolic variables (TC, LDL-c, HDL-c levels and the LDL-c/HDL-c ratio), and to have a higher AUC-ROC and odds ratio than BMI, waist circumference (WC) and the waist to hip ratio (WHR).
CONCLUSION
CONCLUSIONS
The prevalence of MetS and overweight/obesity is elevated in TS subjects. WHtR was the most useful variable in predicting the presence of MetS and overweight and obesity in this TS cohort. A combination of WHtR with BMI or with WC could have the best clinical utility in identifying adult TS subjects with overweight/obesity and MetS, respectively.
Identifiants
pubmed: 31571955
doi: 10.2147/DMSO.S214787
pii: 214787
pmc: PMC6750008
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1795-1809Informations de copyright
© 2019 Álvarez-Nava et al.
Déclaration de conflit d'intérêts
The authors declare that they have nothing to disclose and there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Références
Clin Endocrinol (Oxf). 2017 Nov;87(5):532-538
pubmed: 28617979
Acta Paediatr. 2009 Mar;98(3):513-8
pubmed: 19021594
Eur J Pediatr. 1994 Jan;153(1):11-6
pubmed: 8313917
J Clin Endocrinol Metab. 2006 Oct;91(10):3897-902
pubmed: 16849410
J Clin Endocrinol Metab. 2009 Sep;94(9):3289-96
pubmed: 19567529
Clin Endocrinol (Oxf). 1996 Nov;45(5):589-93
pubmed: 8977756
J Clin Endocrinol Metab. 2006 Aug;91(8):2867-70
pubmed: 16705071
Metab Syndr Relat Disord. 2014 Apr;12(3):159-64
pubmed: 24447068
BBA Clin. 2015 Apr 30;3:304-9
pubmed: 26673162
J Community Health. 2016 Dec;41(6):1223-1233
pubmed: 27315803
Eur J Endocrinol. 2017 Sep;177(3):G1-G70
pubmed: 28705803
Arq Bras Endocrinol Metabol. 2005 Aug;49(4):529-35
pubmed: 16358081
Am J Clin Nutr. 2003 Nov;78(5):902-3
pubmed: 14594773
Clin Endocrinol (Oxf). 2013 Jun;78(6):907-13
pubmed: 23106295
J Clin Endocrinol Metab. 2001 Sep;86(9):4166-70
pubmed: 11549644
J Clin Endocrinol Metab. 2008 Dec;93(12):4735-42
pubmed: 18812477
Am J Clin Nutr. 1995 Apr;61(4):746-53
pubmed: 7702015
Public Health Nutr. 2011 Oct;14(10):1702-13
pubmed: 21486521
Endocr Rev. 2012 Oct;33(5):677-714
pubmed: 22707402
Endocr Rev. 2002 Feb;23(1):120-40
pubmed: 11844747
Diabetes Res Clin Pract. 2005 Jul;69(1):63-77
pubmed: 15955388
J Clin Endocrinol Metab. 2005 May;90(5):2631-5
pubmed: 15713713
Ann Hum Biol. 1984 Jan-Feb;11(1):53-66
pubmed: 6703644
Int J Obes Relat Metab Disord. 2001 Dec;25(12):1794-9
pubmed: 11781760
Circulation. 2004 Jan 27;109(3):433-8
pubmed: 14744958
J Hypertens. 2008 May;26(5):866-70
pubmed: 18398327
Epidemiol Rev. 2007;29:115-28
pubmed: 17494056
Obes Facts. 2009;2(2):97-103
pubmed: 20054212
Eur J Epidemiol. 2001;17(6):521-6
pubmed: 11949723
Front Endocrinol (Lausanne). 2018 Feb 09;9:27
pubmed: 29479339
J Pediatr. 2003 Mar;142(3):336-40
pubmed: 12640385
BMC Genet. 2016 Jun 27;17(1):93
pubmed: 27350247
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
J Clin Res Pediatr Endocrinol. 2008;1(2):62-71
pubmed: 21318066
Hum Biol. 1977 May;49(2):215-23
pubmed: 873486
Eur J Endocrinol. 2006 Oct;155(4):583-92
pubmed: 16990658
Hipertens Riesgo Vasc. 2017 Nov 4;:null
pubmed: 29108814
Int J Pediatr Endocrinol. 2013 Jun 04;2013(1):10
pubmed: 23731950
Gynecol Endocrinol. 2014 Mar;30(3):250-3
pubmed: 24400597